News centre

March 01, 2018

Philips brings new 3.0T MR system to market to spotlight break-through in digital imaging solutions, at ECR


Debuted at ECR 2018, the newest addition to Philips’ digital MR solutions portfolio provides breakthrough in speed, improved patient experience and clinical confidence

 

  • New digital Ingenia Elition 3.0T MR, offering a break-through in image quality and speed for the most challenging clinical situations, while setting new standards for clinical research

Guildford, UK, Amsterdam, The Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it is showcasing its latest digital imaging and advanced visualisation and quantification solutions at the 2018 European Congress of Radiology (ECR) from February 28 through March 4, 2018 in Vienna, Austria.

 

MRI exams up to 50% faster

For the first time, Philips will demonstrate its newest MR solution, Ingenia Elition 3.0T1,  Philips smartest and most patient-friendly MR platform ever. Ingenia Elition, when used with Philips Compressed SENSE2 acceleration technology, can help clinicians perform MRI exams up to 50% faster3 without sacrificing image quality. Utilising intuitive user interfaces, unique in-bore sensing technologies and advanced AI-driven analytics, radiologists can create bespoke planning, scanning and exam processing protocols that can then be automated for easy, quick, reference and redeployment. The Ingenia Elition is helping make the full MR workflow more efficient, cost effective, and consistent to offer both patients and staff increased diagnostic confidence.

Today’s health systems are constantly evolving as they adapt to new and increasing patient needs

Neil Mesher

Philips UKI CEO

“Diagnostic imaging is at the core of many care pathways, with radiology departments facing growing pressure as demand for services increases year on year. To help address these challenges,  Philips has created a solution that utilises innovative and sophisticated technology to provide faster and improved image capture and analysis, whilst at the same time simplifying the user interfaces and controls. Ingenia Elition has been designed to support radiology professionals get to a complete and fast diagnostic picture, and in turn it helps to improve patient outcomes.”

 

Intelligent and patient-friendly MR platform

The Ingenia Elition MR solution delivers patient-centric imaging from patient set-up to the final image. By uniting Philips’ unique dStream digital broadband technology with Compressed SENSE and 3D APT across its new digital MR portfolio, radiologists have the tools necessary to help solve challenging clinical situations, improve the patient experience and set new directions for clinical research.

 

Unique patient sensing technology

New patient sensing technology and AI-driven SmartExam analytics for automatic planning, scanning and processing of exams help improve the entire MR workflow, from image acquisition to reading preference. Ingenia Elition’s VitalScreen offers operators fully guided patient setup with a newly designed user interface for workflow optimisation and VitalEye brings a unique patient sensing approach, enabling respiratory signal without any interaction from the operator. VitalEye technology and algorithms process over two hundred body locations in parallel to intelligently extract signs of breathing – allowing exam set-up time to occur in less than a minute.

 

Philips Ambient Experience and in-bore Connect solution, offers an immersive audio-visual experience to calm patients and guide them through MR exams, further improving the patient experience. A study at Herlev Gentofte University Hospital in Denmark showed that the Ambient Experience in-bore Connect solution helped reduce the number of rescans by up to 70%4, allowing radiologists to handle more patients per day. The unique combination of innovations that the new Ingenia Elition offers is improving the entire workflow from image acquisition to reading preferences.

Philips is committed to offering new intelligent solutions that help address the challenges radiologists face today,

Robert Cascella

Chief Business Leader Diagnosis and Treatment for Royal Philips

“Together with our clinical partners we continue to develop new and ground-breaking technologies that works seamlessly together and are designed to augment the radiologist’s expertise. Our ultimate goal is to enable care professionals to make confident diagnoses, with the use of integrated solutions that provide high quality images, the first time.”

 

Improving diagnosis, treatment and outcomes

Philips is working to break down the silos that currently exist to delivering more seamless care by connecting people, technology and data. At this year’s ECR 2018, Philips will highlight its portfolio of integrated solutions, helping to shape the future of confident diagnosis. This includes:

  • Ingenia Elition 3.0T – The newest addition to the Ingenia MR portfolio is at the forefront of clinical excellence.  Through dStream, and CompressSense, Ingenia delivers extraordinary image quality with speed, and cutting-edge MR imaging techniques for the most challenging clinical situations, while setting new standards for clinical research. The user experience is further improved with touchless automated workflow optimization, such as patient sensing, and fully guided patient setup;
  • Ingenia Prodiva 1.5T - Philips’ Ingenia Prodiva 1.5T MR, using Philips’ dStream digital broadband technology, provides consistent, high-quality images and an enhanced clinical performance, workflow and patient experience. With Breeze Workflow, the new Ingenia Prodiva 1.5T provides a simplified, guided patient setup, supporting fast patient setup;
  • IQon Elite Spectral CT – Debuting at RSNA 2017, the IQon Elite Spectral CT offers a suite of features that will enhance the clinical benefits of the IQon platform to improve diagnostic confidence while enhancing the patient experience within emergency care and oncology;
  • Evolution 4.0 - The next step in our journey of innovation on the EPIQ premium ultrasound platform, with breakthrough eL18-4 PureWave linear transducer technology, new flow imaging capability, and image quality enhancements across a 2broad range of applications.

 

For more information about Philips’ presence at the 2018 European Congress of Radiology, including our virtual reality MR experience, visit www.philips.com/ecr, visit Philips booth (#402) on-site or follow @PhilipsLiveFrom for #ECR18 live updates.

 

1- 510k pending. Not yet CE marked. Not yet available for delivery

2- 510k pending. Not available for sale in the USA or Canada. Not yet CE marked. Not yet available for delivery.

3- With virtually equivalent image quality. Compared to Philips scans without Compressed SENSE

4- Results from case studies are not predictive of results in other cases. Results in other cases may vary

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Read MoreRead Less

Forward-looking statements

This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

Read MoreRead Less

Topics

Contacts

Jon Falcone

Jon Falcone

Integrated Communications Manager,
Health Systems

Tel: + 44 (0) 7711 462 865

Media assets

Press releases

Get our press releases by e-mail

Share on social media